Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Osteoporosis
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
Technology appraisal guidance [TA161]
Published:
27 October 2008
Last updated:
07 February 2018
Guidance
Tools and resources
History
Shared learning examples
Shared learning examples for Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
Title
Type
Year published
No results could be found